1. Home
  2. NTRA vs P Comparison

NTRA vs P Comparison

Compare NTRA & P Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

N/A

Current Price

$378.07

Market Cap

56.7B

Sector

Health Care

ML Signal

N/A

Logo Everpure Inc. Class A common stock

P

Everpure Inc. Class A common stock

N/A

Current Price

$113.34

Market Cap

51.5B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
NTRA
P
Founded
2003
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Electronic Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
56.7B
51.5B
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
NTRA
P
Price
$378.07
$113.34
Analyst Decision
Strong Buy
Buy
Analyst Count
23
20
Target Price
★ $416.39
$151.11
AVG Volume (30 Days)
1.4M
★ 3.0M
Earning Date
11-05-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
0.65
★ 77.42
EPS
N/A
★ 0.28
Revenue
$210,939,000.00
★ $3,662,843,000.00
Revenue This Year
$26.22
$38.00
Revenue Next Year
$20.96
$37.64
P/E Ratio
★ N/A
$455.68
Revenue Growth
N/A
★ 15.61
52 Week Low
$181.00
$65.75
52 Week High
$437.41
$157.57

Technical Indicators

Market Signals
Indicator
NTRA
P
Relative Strength Index (RSI) 43.12 39.37
Support Level $187.64 $90.96
Resistance Level $437.41 $119.10
Average True Range (ATR) 19.55 8.00
MACD -2.75 -2.70
Stochastic Oscillator 5.74 2.76

Price Performance

Historical Comparison
NTRA
P

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About P Everpure Inc. Class A common stock

Everpure Inc is a globalised technology company providing an integrated storage and data management platform. Data is foundational to customers' business transformation and increasingly central to their operational resilience and competitive differentiation. The company has evolved into a company that delivers a cloud experience with an intelligent, unified storage and data management platform (the Everpure Platform) that virtualizes data across on-premises, hybrid, and public cloud, and edge environments into a single storage layer with consistent control, built-in automation, and continuous modernization. Its business activities are a single operating and reportable segment. Operating in the USA and Rest of world, having maximum revenue in the USA.

Share on Social Networks: